These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16635077)

  • 1. Recombinant activated factor VIIa (rFVIIa) in intractable haemorrhage: use of a clinical scoring system.
    Pugh R; Wenstone R; Goh N
    Vox Sang; 2006 May; 90(4):331; author reply 332. PubMed ID: 16635077
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant factor VIIa (rFVIIa) in the management of intractable haemorrhage: a survey of current UK practice.
    Biss TT; Hanley JP
    Br J Haematol; 2007 Jul; 138(1):126-8. PubMed ID: 17555457
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
    Kogan A; Berman M; Stein M; Vidne BA; Raanani E
    J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidotes to haemorrhage: recombinant factor VIIa.
    Kessler CM
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa for life-threatening post-partum haemorrhage.
    Ahonen J; Jokela R
    Br J Anaesth; 2005 May; 94(5):592-5. PubMed ID: 15708871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective.
    Clark AD; Gordon WC; Walker ID; Tait RC
    Vox Sang; 2004 Feb; 86(2):120-4. PubMed ID: 15023181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
    Cervera JS; Mena-Durán AV; Piqueras CS
    Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
    Geeraedts LM; Kamphuisen PW; Kaasjager HA; Verwiel JM; van Vugt AB; Frölke JP
    Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII increases survival time in a model of incompressible arterial hemorrhage in the anesthetized pig.
    Sapsford W; Watts S; Cooper G; Kirkman E
    J Trauma; 2007 Apr; 62(4):868-79. PubMed ID: 17426541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
    Kessler C
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S228-34. PubMed ID: 12404091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use].
    Courtois L; Becher P; Miot S; Maisonnette-Escot Y; Sautière JL; Berthier F; Samain E; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):78-82. PubMed ID: 17293258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation.
    Shenoy A; Savani BN; Barrett AJ
    Biol Blood Marrow Transplant; 2007 May; 13(5):622-3. PubMed ID: 17448923
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
    Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rFVIIa (Novoseven): the new panacea?
    Ickx BE
    Acta Anaesthesiol Belg; 2003; 54(4):333-5. PubMed ID: 14719355
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated prothrombin complex concentrates and recombinant factor VIIa in the bleeding patient: are they appropriate and safe?
    Aledort LM
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2112-3. PubMed ID: 14688750
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent.
    Dunkley SM; Mackie F
    Hematology; 2003 Aug; 8(4):263-4. PubMed ID: 12911945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
    Dhruva KK; Joel VD; Antony S; Vinodan K
    J Indian Med Assoc; 2006 Jan; 104(1):42, 44. PubMed ID: 16850866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.